-
-15%
INNORYOS SIR INTRA-ART2,2% 2ML
85.50€
100.59€
- Brand: LIFE MED Srls
- Product Code: 984821405
- EAN: 4250311910345
- Availability: In Stock
- Purchase 3 items for 83.79€ each
- Purchase 4 items for 82.08€ each
- Purchase 5 items for 80.37€ each
INNORYOS
Description
The product contains a prepackaged injection of hydrogel containing highly purified sodium hyaluronate, obtained by bacterial fermentation with high molecular weight, useful for improving the viscosity of intra-articular connective tissue. It has been steam sterilized for injectable products and is non-pyrogenic.
One milliliter of aqueous and physiological phosphate buffer solution contains 16 mg, 22 mg or 25 mg of sodium hyaluronate, depending on the product variant and concentration. The hyaluronic acid hydrogel is found in a weak, sterile, isotonic and pyrogenic saline phosphate buffer solution with a pH of 7.2 (6.8 - 7.4) and a volume sufficient for injection. Filling volumes are 1 - 4.8 ml, depending on the variant.
The widely distributed hyaluronic acid glycosaminoglycan is a fundamental component of healthy synovial fluid. This natural biopolymer ensures viscoelasticity and makes possible, thanks to its lubricating and shock-absorbing characteristics, pain-free physiological movements; it also provides nutrients to the cartilage. The sodium hyaluronate contained in INNORYOS is a salt of hyaluronic acid.
Pain and limited joint mobility in case of degenerative changes in the knee joint and other synovial joints, including osteoarthritis.
How to use
The prepackaged syringe must be taken out of its package. The protective cap must be removed from the Luer-Lock thread. Screw a suitable sterile injection needle onto the syringe. The use of a disposable needle is recommended. Before the injection it is necessary to purge the air from the syringe. The part of the skin intended for injection must be cleansed with an appropriate topical antiseptic product. In case of joint effusion, it is recommended to reduce the effusion by aspiration and to examine the bacterial etiology, before proceeding with the injection of INNORYOS. The hydrogel can be injected intra-articularly from 1 to 5 times at intervals determined by the doctor. The beneficial effects of a treatment last at least 6 months. The treatment cycles can be repeated if necessary.
Depending on the filling volume, several joints in a patient can be treated simultaneously. Unused product should be discarded.
Warnings
The product cannot be applied in patients presenting:
- a known sensitivity against one of the components;
- an inflammation of the joint;
- a septic arthritis;
- skin infections or skin diseases in the injection area;
- natural or pharmacological reduction of coagulation such as haemophilia or in anticoagulant therapy such as eg. Marcumar (phenprocoumon) or Coumadin (warfarin).
Since there are no clinical data on the use of hyaluronic acid in children, pregnant or breastfeeding women, it is not recommended for these categories of people.
Since septic arthritis can be a serious side effect of treatment, please observe all precautionary measures typical of surgery. Injections of hydrogel must be done exactly in the cavity of the knee; injections into blood vessels and adjacent tissue should be avoided. Do not use if the prepackaged syringe or sterile packaging is damaged. The opened product cannot be re-sterilized, re-closed or reused. The use is reserved for a single patient in a single application session.
At the treated joint they can v
The product contains a prepackaged injection of hydrogel containing highly purified sodium hyaluronate, obtained by bacterial fermentation with high molecular weight, useful for improving the viscosity of intra-articular connective tissue. It has been steam sterilized for injectable products and is non-pyrogenic.
One milliliter of aqueous and physiological phosphate buffer solution contains 16 mg, 22 mg or 25 mg of sodium hyaluronate, depending on the product variant and concentration. The hyaluronic acid hydrogel is found in a weak, sterile, isotonic and pyrogenic saline phosphate buffer solution with a pH of 7.2 (6.8 - 7.4) and a volume sufficient for injection. Filling volumes are 1 - 4.8 ml, depending on the variant.
The widely distributed hyaluronic acid glycosaminoglycan is a fundamental component of healthy synovial fluid. This natural biopolymer ensures viscoelasticity and makes possible, thanks to its lubricating and shock-absorbing characteristics, pain-free physiological movements; it also provides nutrients to the cartilage. The sodium hyaluronate contained in INNORYOS is a salt of hyaluronic acid.
Pain and limited joint mobility in case of degenerative changes in the knee joint and other synovial joints, including osteoarthritis.
How to use
The prepackaged syringe must be taken out of its package. The protective cap must be removed from the Luer-Lock thread. Screw a suitable sterile injection needle onto the syringe. The use of a disposable needle is recommended. Before the injection it is necessary to purge the air from the syringe. The part of the skin intended for injection must be cleansed with an appropriate topical antiseptic product. In case of joint effusion, it is recommended to reduce the effusion by aspiration and to examine the bacterial etiology, before proceeding with the injection of INNORYOS. The hydrogel can be injected intra-articularly from 1 to 5 times at intervals determined by the doctor. The beneficial effects of a treatment last at least 6 months. The treatment cycles can be repeated if necessary.
Depending on the filling volume, several joints in a patient can be treated simultaneously. Unused product should be discarded.
Warnings
The product cannot be applied in patients presenting:
- a known sensitivity against one of the components;
- an inflammation of the joint;
- a septic arthritis;
- skin infections or skin diseases in the injection area;
- natural or pharmacological reduction of coagulation such as haemophilia or in anticoagulant therapy such as eg. Marcumar (phenprocoumon) or Coumadin (warfarin).
Since there are no clinical data on the use of hyaluronic acid in children, pregnant or breastfeeding women, it is not recommended for these categories of people.
Since septic arthritis can be a serious side effect of treatment, please observe all precautionary measures typical of surgery. Injections of hydrogel must be done exactly in the cavity of the knee; injections into blood vessels and adjacent tissue should be avoided. Do not use if the prepackaged syringe or sterile packaging is damaged. The opened product cannot be re-sterilized, re-closed or reused. The use is reserved for a single patient in a single application session.
At the treated joint they can v